Premium
Experience with Intravenous Immunoglobulin Treatment in Neonates and Pregnant Women
Author(s) -
Muralt Gaspard,
Sidiropoulos D.
Publication year - 1986
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.1986.tb02003.x
Subject(s) - medicine , gestation , antibody , pregnancy , obstetrics , intravenous immunoglobulins , pediatrics , immunology , genetics , biology
. Results of 2 methods to treat infection in the neonate are reported. One study demonstrates a decrease in mortality and recurrent infection when neonates with septicemia were given intravenous immunoglobulin (IVIG). In another study, IVIG was administered to pregnant women with symptoms of infection and at risk for preterm delivery. IVIG infused at high doses after 32 weeks of gestation significantly decreased infection in newborns without affecting term.